Our BIOMIMESYS® Adipose tissue extracellular matrix expands our 3D study possibilities ! HCS Pharma offers you a new 3D test for the evaluation of slimming properties of your actives ingredients. It offers you the possibility to observe the fat-inhibiting potential Read more…
Last week HCS Pharma was pleased to take part to Elrig Uk Research & Innovation. This event took place on the 20 and 21 March in Manchester. It was a great opportunity to share another time our technology with the Read more…
The annual “Research and Innovation” congress by ELRIG UK will take place on 20 and 21 March in Manchester. We are delighted to participate in this event with a poster presentation and a booth in the BreakThough Zone! Our poster Read more…
RIKEN, equivalent to CNRS in France, is a national research and development agency based in Japan and is the largest comprehensive research institution in the country. After RIKEN symposium held in Belgium on February 14 where Dr Nathalie Maubon, our Read more…
During this time of celebrating the Chinese New Year, HCS Pharma extends its best wishes to all those observing this special occasion. This year, the transition to the Year of the Dragon promises to bring strength, courage, and growth opportunities. Read more…
On this day dedicated to love, we celebrate the passion that exists even on a microscopic scale. Because here, even our 3D models are animated by the magic of Valentine’s Day! The entire HCS Pharma team wishes you a happy Read more…
Lille, February 5, 2024HCS Pharma, a pioneering biotechnology company that enables the recreation of human organ avatars in vitro, announces that its BIOMIMESYS® technology has played a key role in the scientific discoveries of the teams led by Professor Robert-Alain Read more…
A great way to ended the year 2023! The participation of Dr. Nathalie MAUBON and Dr. Meryl ROUDAUT to represent HCS Pharma at HACKOSAKA event in december 2023 in Japan was an excellent opportunity to once again promote the results Read more…
HCS Pharma est une société de biotechnologie axée sur la R&D in vitro qui développe ses propres modèles cellulaires 3D grâce à sa technologie brevetée BIOMIMESYS®. La technologie de culture 3D BIOMIMESYS® consiste en un Hydroscaffold™ qui reproduit fidèlement le Read more…
HCS Pharma start the year 2024 with a brand new strength! The new laboratories are welcome to continue to satisfy medical researchers and receive more and more demand from all around the world for our physiological and biological matrix BIOMIMESYS®. Read more…
Did you know that Epiphany, is celebrated on January 6th? Traditionally, this day is also associated with the enjoyment of the King’s Cake, a pastry made of puff pastry and frangipane enjoyed by young and old alike. Why King? Because Read more…
HCS Pharma wishes you an excellent year 2024 full of rebound, laughter, joy, and innovation! As the clocks mark the passage of time, a wave of optimism fills the minds. Technological advances, scientific discoveries and commitments to sustainability promise of Read more…
We are delighted to announce that a very interesting study using BIOMIMESYS® to study the metastasis of breast cancer has been published in Experimental Hematology & Oncology Journal (Impact factor 11,4). This article untitled “ProNGF promotes brain metastasis through TrkA/EphA2 Read more…
This November, HCS Pharma, a pioneer in cell modelling technologies, is joining the global “Movember” initiative to raise awareness and support for prostate cancer research. As a key player in the health sector, we are proud to be taking part Read more…
November was the smoked-free month, and we hope that it was successful for you!* Indeed, smoking is the first cause of lung cancer, which is the 3th most common cancer and the first leading cause of cancer-related mortality in France, Read more…
Thanks to our collaboration with the Institute for Regenerative Medicine and Biotherapy in Montpellier, HCS Pharma is now actively contributing to the advancement of a 3D in vitro model of osteoarthritic cartilage using the technology BIOMIMESYS®. Our PhD student, Marina Read more…
HCS Pharma announces the closure of the “MIMLIVERonChip” project, funded by the French National Research Agency (ANR, project ANR 19 CE19-0020) and coordinated by BMBI Biomechanics and Bioengineering joint research unit (UTC/ CNRS), headed by Dr Cécile Legallais, CNRS research Read more…
HCS Pharma marked its presence at ELRIG UK Drug Discovery 2023, demonstrating its commitment to innovation in drug discovery. At this major pharmaceutical industry event, with the presence of Veronique De Conto (Project Leader in in vitro Pharmacology) and Paul Read more…
Yesterday Julien Cicero defended his PhD thesis in OncoLille Institute, about the role of neurotrophins and related receptors in brain metastasis of triple negative breast cancer. What a great thesis defense, we enjoyed a lot his very clear presentation and Read more…
Our 3D HydroscaffoldTM matrix BIOMIMESYS® cultures bring out the darkest secrets of human organs, perfect for a spooky Halloween experience. Would you be interested in a tutorial on how to count pumpkins in 3D in BIOMIMESYS®?
Once again this year, the Cosmetic 360 trade show lived up to its promise ! Numerous beauty and health professionals including HCS Pharma were present on October 18th and 19th in Paris. Services, finished products or ingredients, essential oils, the Read more…
ELRIG Drug Discovery 2023 congress will take place in Liverpool next week (October, 18 & 19th 2023). Our project leader Dr. Véronique De Conto will have the pleasure for presenting a poster about High Content Screening in 3D models including Read more…
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
